2018
DOI: 10.3390/v10120729
|View full text |Cite
|
Sign up to set email alerts
|

Cervical Cancer Screening Programs in Europe: The Transition Towards HPV Vaccination and Population-Based HPV Testing

Abstract: Cervical cancer is the fourth most frequently occurring cancer in women around the world and can affect them during their reproductive years. Since the development of the Papanicolaou (Pap) test, screening has been essential in identifying cervical cancer at a treatable stage. With the identification of the human papillomavirus (HPV) as the causative agent of essentially all cervical cancer cases, HPV molecular screening tests and HPV vaccines for primary prevention against the virus have been developed. Accor… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

2
172
0
19

Year Published

2019
2019
2022
2022

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 197 publications
(210 citation statements)
references
References 310 publications
2
172
0
19
Order By: Relevance
“…As per the WHO guidelines, there has been a global shift to HPV-based cervical screening 4. Worldwide, countries including the UK, Ireland, Netherlands and Turkey have implemented national HPV-based cervical screening, with many more transitioning towards primary HPV testing 5 6. Previous international studies stated most women are unaware of the use of primary HPV testing7 and that some women may experience a negative emotional response towards primary HPV testing as it is a sexually transmitted infection 8 9.…”
Section: Introductionmentioning
confidence: 99%
“…As per the WHO guidelines, there has been a global shift to HPV-based cervical screening 4. Worldwide, countries including the UK, Ireland, Netherlands and Turkey have implemented national HPV-based cervical screening, with many more transitioning towards primary HPV testing 5 6. Previous international studies stated most women are unaware of the use of primary HPV testing7 and that some women may experience a negative emotional response towards primary HPV testing as it is a sexually transmitted infection 8 9.…”
Section: Introductionmentioning
confidence: 99%
“…HPV testing alone or co-testing is the main difference between the European and American guidelines: the American guidelines recommend co-testing with HPV and cytology, [ 27 ] while the European guidelines recommend HPV alone. [ 28 ] China has a large population and regional economic distribution. The current cervical cancer screening program in China is implemented in a “3-Step” strategy, including TCT, HPV testing, and colposcopy, and is carried out in a diversified manner, adopting different screening strategies for different groups of people.…”
Section: Discussionmentioning
confidence: 99%
“…according to the european Guidelines, as well as the world health Organization (whO), hPV testing is now proposed as the primary screening tool for cervical cancer [13,14]. there are several countries in europe and all over the world integrating hPV vaccination and population-based hPV testing in cervical cancer screening programmes [15]. Nevertheless, in Poland, the cervical cancer screening programme is based on the conventional Pap test, repeated every three years among women aged 25-69 [16].…”
Section: Introductionmentioning
confidence: 99%